Prince Pharmaceutical Co (ROCO:6935) Revenue per Share : NT$19.87 (TTM As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Prince Pharmaceutical Co Revenue per Share?

Prince Pharmaceutical Co's revenue per share for the six months ended in Jun. 2024 was NT$9.30. Prince Pharmaceutical Co's revenue per share for the trailing twelve months (TTM) ended in Jun. 2024 was NT$19.87.

During the past 12 months, the average Revenue Per Share Growth Rate of Prince Pharmaceutical Co was -1.10% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 31.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Prince Pharmaceutical Co's Revenue per Share or its related term are showing as below:

ROCO:6935' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 31.6 Med: 35.8 Max: 40
Current: 31.6

During the past 5 years, Prince Pharmaceutical Co's highest 3-Year average Revenue Per Share Growth Rate was 40.00% per year. The lowest was 31.60% per year. And the median was 35.80% per year.

ROCO:6935's 3-Year Revenue Growth Rate is ranked better than
91.11% of 911 companies
in the Drug Manufacturers industry
Industry Median: 6.4 vs ROCO:6935: 31.60

Prince Pharmaceutical Co Revenue per Share Historical Data

The historical data trend for Prince Pharmaceutical Co's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prince Pharmaceutical Co Revenue per Share Chart

Prince Pharmaceutical Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Revenue per Share

7.79

9.04

13.29

21.38

20.61

Prince Pharmaceutical Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Revenue per Share	Get a 7-Day Free Trial				11.32	10.06	10.02	10.58	9.30

Competitive Comparison of Prince Pharmaceutical Co's Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Prince Pharmaceutical Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prince Pharmaceutical Co's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Prince Pharmaceutical Co's PS Ratio distribution charts can be found below:

* The bar in red indicates where Prince Pharmaceutical Co's PS Ratio falls into.

Prince Pharmaceutical Co Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Prince Pharmaceutical Co's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )	=	Revenue (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	753.327	/	36.546
	=	20.61

Prince Pharmaceutical Co's Revenue Per Share for the quarter that ended in Jun. 2024 is calculated as

Revenue Per Share (Q: Jun. 2024 )	=	Revenue (Q: Jun. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2024 )
	=	339.819	/	36.555
	=	9.30

Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$19.87

Prince Pharmaceutical Co (ROCO:6935) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Prince Pharmaceutical Co Revenue per Share Related Terms

Thank you for viewing the detailed overview of Prince Pharmaceutical Co's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Prince Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prince Pharmaceutical Co Ltd (ROCO:6935) » Definitions » Revenue per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 168, Keyunnan Road, Huwei Town, Yunlin, TWN, 632

Website

https://www.prince-pharm.com.tw

Prince Pharmaceutical Co Ltd is engaged in the manufacturing, packaging, processing, and trading of various active pharmaceutical ingredients and health supplements. The company supplies its products to Taiwan, Japan, Spain, Europe and other regions.

Prince Pharmaceutical Co Headlines

No Headlines